JP2003206241A5 - - Google Patents

Download PDF

Info

Publication number
JP2003206241A5
JP2003206241A5 JP2002004250A JP2002004250A JP2003206241A5 JP 2003206241 A5 JP2003206241 A5 JP 2003206241A5 JP 2002004250 A JP2002004250 A JP 2002004250A JP 2002004250 A JP2002004250 A JP 2002004250A JP 2003206241 A5 JP2003206241 A5 JP 2003206241A5
Authority
JP
Japan
Prior art keywords
ophthalmic
pharmacologically active
low molecular
active compound
ophthalmic agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002004250A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003206241A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2002004250A priority Critical patent/JP2003206241A/ja
Priority claimed from JP2002004250A external-priority patent/JP2003206241A/ja
Publication of JP2003206241A publication Critical patent/JP2003206241A/ja
Publication of JP2003206241A5 publication Critical patent/JP2003206241A5/ja
Pending legal-status Critical Current

Links

JP2002004250A 2002-01-11 2002-01-11 眼科用剤 Pending JP2003206241A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2002004250A JP2003206241A (ja) 2002-01-11 2002-01-11 眼科用剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2002004250A JP2003206241A (ja) 2002-01-11 2002-01-11 眼科用剤

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2003392022A Division JP2004043516A (ja) 2003-11-21 2003-11-21 眼科用剤

Publications (2)

Publication Number Publication Date
JP2003206241A JP2003206241A (ja) 2003-07-22
JP2003206241A5 true JP2003206241A5 (enExample) 2004-11-18

Family

ID=27643621

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002004250A Pending JP2003206241A (ja) 2002-01-11 2002-01-11 眼科用剤

Country Status (1)

Country Link
JP (1) JP2003206241A (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2005072727A1 (ja) * 2004-01-29 2007-09-06 テイカ製薬株式会社 点眼剤組成物
WO2005079809A1 (ja) * 2004-02-19 2005-09-01 Santen Pharmaceutical Co., Ltd. 澄明なラタノプロスト点眼液
JP2005263792A (ja) * 2004-02-19 2005-09-29 Santen Pharmaceut Co Ltd 澄明なラタノプロスト点眼液
JP5434981B2 (ja) * 2004-02-27 2014-03-05 大正製薬株式会社 点眼剤
JP4961671B2 (ja) * 2004-02-27 2012-06-27 大正製薬株式会社 点眼剤
JP5575100B2 (ja) * 2004-12-28 2014-08-20 ロート製薬株式会社 プラノプロフェン含有組成物
JP4958401B2 (ja) * 2004-12-28 2012-06-20 ロート製薬株式会社 プラノプロフェン含有組成物
DE102005055275A1 (de) * 2005-11-17 2007-05-24 Ursapharm Arzneimittel Gmbh & Co. Kg Phosphatfreie pharmazeutische Zusammensetzung sowie deren Verwendung
EP2123278B1 (en) * 2007-02-07 2013-01-09 Teika Pharmaceutical Co., Ltd. Eye drop preparation comprising latanoprost
JP5420877B2 (ja) * 2008-10-07 2014-02-19 テイカ製薬株式会社 眼科用剤
JP2010132587A (ja) * 2008-12-03 2010-06-17 Teika Seiyaku Kk 眼科用剤
JP5489581B2 (ja) * 2009-06-29 2014-05-14 ロート製薬株式会社 プラノプロフェン含有水性組成物
TW201109325A (en) * 2009-07-30 2011-03-16 Wakamoto Pharma Co Ltd Aqueous composition for eye drops
JP2011219412A (ja) * 2010-04-09 2011-11-04 Saisentan Igaku Kenkyusho:Kk 緑内障の視野改善治療薬
JP6704720B2 (ja) * 2014-12-12 2020-06-03 興和株式会社 水性な組成物
JP6918564B2 (ja) * 2017-05-01 2021-08-11 参天製薬株式会社 水性医薬組成物

Similar Documents

Publication Publication Date Title
JP2003206241A5 (enExample)
JP2015025011A5 (enExample)
ES2374336T3 (es) Agente profiláctico o terapéutico para una enfermedad ocular posterior que comprende un agonista selectivo no ergótico del receptor d2 como principio activo.
WO2001030337A3 (en) Ophthalmic formulation of dopamine antagonists
JP4582822B2 (ja) 眼における滞留時間の長い目薬組成物
TWI343918B (en) Compositions and methods for treating, controlling, reducing, or ameliorating infections and sequelae thereof
JP2011006448A (ja) 第四級化アンモニウムシクロデキストリン化合物
ATE428401T1 (de) Suspensionsformulierungen mit einem aktiven wirkstoff, einem poloxamer- oder meroxapol-tensid und einem glycol und ihre verwendung zur herstellung eines medikaments zur behandlung von augenkrankheiten
BR0317572A (pt) Benzoxazinas e seus derivados como inibidores de pi3ks
JP2005527605A5 (enExample)
RU2012103538A (ru) Композиции и способы ингибирования пути jak
JPH1160505A (ja) 防腐組成物
CA2582316A1 (en) Use of inhibitors of jun n-terminal kinases for the treatment of glaucomatous retinopathy and ocular diseases
JP5700479B2 (ja) シリコーンハイドロゲルコンタクトレンズ用点眼剤
JP2003206241A (ja) 眼科用剤
TWI336701B (en) Compositions and methods for treating or preventing glaucoma or progression thereof
AU2001278708A1 (en) Adenosine derivatives and use thereof
TW200911286A (en) Compositions and methods for treating or controlling anterior-segment inflammation
JPWO2015041193A1 (ja) 両性イオン性ソフトコンタクトレンズ用眼科用組成物
KR950701329A (ko) 벤조티아졸술폰아미드 유도체, 그의 제조법 및 그 용도(Benzothiazolesulfornamide derivative, method for preparing the same, and use thereof)
NO20070421L (no) Radiosensitiviserende middel
KR20160138179A (ko) 수성 의약 조성물
WO2002051431A1 (fr) Agents therapeutiques et/ou preventifs pour des maladies dues a l'ischemie retinienne
WO2003051351A1 (es) Suspension oftalmica de rofecoxib para el tratamiento de la inflamacion y el dolor ocular
JP4239036B2 (ja) 改良薬剤組成物